Treatment Innovations

Advancing Post-Operative Care: BRIJ Medical Launches Innovative BRIJ-SEAL Incision Management System

• Treatment Innovations

Advancing Post-Operative Care: BRIJ Medical Launches Innovative BRIJ-SEAL Incision Management System

Nana Muazin July 21, 2026

In the evolving landscape of surgical technology, the focus has increasingly shifted toward optimizing patient recovery and...

Read More Read more about Advancing Post-Operative Care: BRIJ Medical Launches Innovative BRIJ-SEAL Incision Management System

Tempus AI Set to Acquire Personalis: A Strategic Consolidation in the Cancer Diagnostics Landscape

• Treatment Innovations

Tempus AI Set to Acquire Personalis: A Strategic Consolidation in the Cancer Diagnostics Landscape

Dwi Wanna July 21, 2026

In a move that signals a significant shift in the oncology diagnostics market, Tempus AI, a leader...

Read More Read more about Tempus AI Set to Acquire Personalis: A Strategic Consolidation in the Cancer Diagnostics Landscape

A New Chapter in B2B Media: WTWH Media Rebrands to Arrowfly

• Treatment Innovations

A New Chapter in B2B Media: WTWH Media Rebrands to Arrowfly

Raul Delapena Setiawan July 20, 2026

In a significant strategic evolution within the business-to-business (B2B) media landscape, Cleveland-based WTWH Media—the parent organization behind...

Read More Read more about A New Chapter in B2B Media: WTWH Media Rebrands to Arrowfly

GE HealthCare Revolutionizes Remote Diagnostics with the Launch of MIM Anyware

• Treatment Innovations

GE HealthCare Revolutionizes Remote Diagnostics with the Launch of MIM Anyware

Jia Lissa July 20, 2026

Main Facts: Breaking Down the MIM Anyware Innovation GE HealthCare has officially unveiled MIM Anyware, a sophisticated,...

Read More Read more about GE HealthCare Revolutionizes Remote Diagnostics with the Launch of MIM Anyware

Westlake-Based Latigo Biotherapeutics Enters Public Markets Amid Non-Opioid Painkiller Race

• Treatment Innovations

Westlake-Based Latigo Biotherapeutics Enters Public Markets Amid Non-Opioid Painkiller Race

Iffa Jayyana July 20, 2026

By Jacob Bell Published July 20, 2026 The biotechnology sector’s long-awaited IPO window has swung wide open...

Read More Read more about Westlake-Based Latigo Biotherapeutics Enters Public Markets Amid Non-Opioid Painkiller Race

British Business Bank Fortifies UK Life Sciences with €25m Commitment to EQT’s Health Economics 3 Fund

• Treatment Innovations

British Business Bank Fortifies UK Life Sciences with €25m Commitment to EQT’s Health Economics 3 Fund

Raul Delapena Setiawan July 20, 2026

In a significant move to bolster the United Kingdom’s position as a global leader in life sciences...

Read More Read more about British Business Bank Fortifies UK Life Sciences with €25m Commitment to EQT’s Health Economics 3 Fund

Rescuing Innovation: How the Children’s Tumor Foundation is Unlocking Pharma’s Shelved Rare Disease Assets

• Treatment Innovations

Rescuing Innovation: How the Children’s Tumor Foundation is Unlocking Pharma’s Shelved Rare Disease Assets

Lina Hope July 20, 2026

In the high-stakes world of pharmaceutical development, the path from a lab bench to an FDA approval...

Read More Read more about Rescuing Innovation: How the Children’s Tumor Foundation is Unlocking Pharma’s Shelved Rare Disease Assets

The Rise of the Hybrid Drug: How Remepy is Rewriting the Parkinson’s Playbook

• Treatment Innovations

The Rise of the Hybrid Drug: How Remepy is Rewriting the Parkinson’s Playbook

Asep Darmawan July 19, 2026

In the early years of the smartphone revolution, the tech industry coined a mantra that would eventually...

Read More Read more about The Rise of the Hybrid Drug: How Remepy is Rewriting the Parkinson’s Playbook

Blazing New Paths: The Strategic Evolution of American Biotech in a Globalized Market

• Treatment Innovations

Blazing New Paths: The Strategic Evolution of American Biotech in a Globalized Market

Ammar Sabilarrohman July 19, 2026

For the better part of a decade, the American biotechnology sector has faced a mounting crisis of...

Read More Read more about Blazing New Paths: The Strategic Evolution of American Biotech in a Globalized Market

Beyond Weight Loss: Boehringer Ingelheim Targets MASH as the Next Frontier for Survodutide

• Treatment Innovations

Beyond Weight Loss: Boehringer Ingelheim Targets MASH as the Next Frontier for Survodutide

Neng Nana July 19, 2026

For decades, metabolic dysfunction-associated steatohepatitis (MASH)—formerly known as non-alcoholic steatohepatitis (NASH)—was widely considered the “graveyard of drug...

Read More Read more about Beyond Weight Loss: Boehringer Ingelheim Targets MASH as the Next Frontier for Survodutide